Growth stocks
With the recent pop in growth stocks (following the “dovish pivot” interpretation of the Fed by the market, an interpretation that we think is false) many once again carry implied earnings trajectories that they haven’t a hope of realising, collectively.
Maybe 5 out of 40 below will.
We own 2 of these, CSL, to get some exposure to the Quality factor loading, that is otherwise quite hard to come by, and TPG, which trades at 33x time earnings, but is only ~0.9x book, or 7x EV/EBIT.
So not all the multiples look quite so aggressive, and we feel fairly comfortable with a telecom trading at 25x PE, as TLS does, so, on net, we don’t think it is much of a worry, provided that it doesn’t indeed grow earnings, which we think it will.
As for the other names, well, we continue to avoid them. FPH was very tempting, after the recent enormous downgrade, but the market didn’t react much, so we continue to not buy it.
How sizeable would falls need to be? Well, think a halving for WTC. $130 for COH.
That sort of thing.
Important Information: This document has been prepared by Aequitas Investment Partners ABN 92 644 165 266 (“Aequitas”, “our”, “we”), a Corporate Authorised Representative (no. 1284389) of C2 Financial Services, (Australian Financial Services Licensee no. 502171), and is for distribution within Australia to wholesale clients and financial advisers only.
This document is based on information available at the time of publishing, information which we believe is correct and any opinions, conclusions or forecasts are reasonably held or made as at the time of its compilation, but no warranty is made as to its accuracy, reliability or completeness. To the extent permitted by law, neither Aequitas nor any of its affiliates accept liability to any person for loss or damage arising from the use of the information herein.
Please note that past performance is not a reliable indicator of future performance.
General Advice Warning: This document has been prepared without taking into account your objectives, financial situation or needs, and therefore you should consider its appropriateness, having regard to your objectives, financial situation and needs. Before making any decision about whether to acquire a financial product, you should obtain and read the relevant Product Disclosure Statement (PDS) or Investor Directed Portfolio Service Guide (IDPS Guide) and consider talking to a financial adviser.
Taxation warning: Any taxation considerations are general and based on present taxation laws and may be subject to change. Aequitas is not a registered tax (financial) adviser under the Tax Agent Services Act 2009 and investors should seek tax advice from a registered tax agent or a registered tax (financial) adviser if they intend to rely on this information to satisfy the liabilities or obligations or claim entitlements that arise, or could arise, under a taxation law.